Proline-rich protein 5 (PRR5), also known as Protor-1, is a proline-rich protein expressed abundantly in kidney and is conserved. PRR5 is a component of the mammalian target of rapamycin complex 2 (mTORC2). Alternative splicing and the use of alternative promoters results in five transcripts encoding different isoforms. The PRR5 gene is mapped to human chromosome 22q13.31.
Specificity
Anti-PRR5 recognizes human PRR5.
Immunogen
synthetic peptide corresponding to an internal region of human PRR5, conjugated to KLH. The corresponding sequence is identical in mouse and rat
Application
Anti-PRR5 antibody produced in rabbit is suitable for immunoblotting.
Biochem/physiol Actions
The proline-rich protein 5 (PRR5) gene exhibits tumor suppression action. It may be associated with breast and colorectal tumorigenesis. PRR5 controls the expression of platelet-derived growth factor (PDGF) receptor β and mediates PDGF signaling to protein kinase B (Akt) and S6 Kinase 1 (S6K1).
Physical form
Solution in 0.01 M phosphate buffered saline pH 7.4, containing 15 mM sodium azide.
Storage and Stability
For continuous use, store at 2-8 °C for up to one month. For extended storage freeze in working aliquots. Repeated freezing and thawing is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.
Disclaimer
Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
The Journal of biological chemistry, 282(35), 25604-25612 (2007-06-30)
The protein kinase mammalian target of rapamycin (mTOR) plays an important role in the coordinate regulation of cellular responses to nutritional and growth factor conditions. mTOR achieves these roles through interacting with raptor and rictor to form two distinct protein
Loss of heterozygosity on chromosome 22q13.31 is a frequent event during human breast and colorectal carcinogenesis. Herein we characterize a novel gene at chromosome 22q13.31 designated PRR5. Alternative promoter usage and splicing converge to generate five PRR5 transcript variants with
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.